A long-term safety and efficacy study of trifarotene 50 ?g/g cream in subjects with facial and truncal acne vulgaris - 22/08/19
Ulrike Blume-Peytavi, MD, Department of Dermatology And Allergy, Charité-Universitätsmedizin Berlin, Berlin, Germany; Emil Tanghetti, MD, Center for Dermatology And Laser Surgery, Sacramento, CA; Lajos Kemény, MD, Department of Dermatology and Allergy, University of Szeged, Szeged, Hungary; Zoe Draelos, MD, Dermatology Consulting Services, Pllc, High Point, NC; Thomas Dirschka, MD, Centroderm Clinic, Wuppertal, Germany; Lawrence Eichenfield, MD, Department of Pediatric and Adolescent Dermatology, Rady Children’s Hospital, University of California, San Diego, School of Medicine, San Diego, CA; Phoebe Rich, MD, Oregon Dermatology and Research, Portland, OR; Michael Graeber, MD, Galderma Research and Development Llc, Fort Worth, TX; Alessandra Alió Saenz, MD, Galderma Research and Development Llc, Fort Worth, TX; Joseph Fowler, MD, University of Louisville, Division of Dermatology; Louisville, KY
Le texte complet de cet article est disponible en PDF.| Supported by Galderma R&D, LLC. |
Vol 81 - N° 4S1
P. AB157 - octobre 2019 Retour au numéro
Article précédent
- A first case of linear and whorled nevoid hypermelanosis associated with lichen planus
- A multi-center, open-label, prospective study of cannula injection of large-gel particle hyaluronic acid with lidocaine for cheek augmentation and the correction of age related midface contour deficiencies
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?